1,2-Diaminocyclohexane → (S)-3-(1H-benzo[d]imidazol-5-yl)-4-isopropyloxazolidin-2-one
反応式
[CH:1]([C@H:4]1[CH2:8][O:7][C:6](=[O:9])[NH:5]1)([CH3:3])[CH3:2].I[C:11]1[CH:12]=[C:13]([NH2:18])[C:14]([NH2:17])=[CH:15][CH:16]=1.[F-].[Cs+].[CH:21]1(N)CCCCC1N.C(OCC)(OCC)OCC>[Cu]I>[NH:18]1[C:13]2[CH:12]=[CH:11][C:16]([N:5]3[C@@H:4]([CH:1]([CH3:3])[CH3:2])[CH2:8][O:7][C:6]3=[O:9])=[CH:15][C:14]=2[N:17]=[CH:21]1参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
The compound was synthesized starting from (S)-4-isopropyloxazolidin-2-one (0.065 g, 0.5 mmol), 4-iodobenzene-1,2-diamine (0.117 g, 0.5 mmol), copper(I) iodide (0.010 g, 0.05 mmol), cesium fluoride (0.276 g, 1 mmol), cyclohexane-1,2-diamine (0.006 mL, 0.05 mmol), triethyl orthoformate (3 mL) as described in method 5 step D.
後処理
- customThe compound was synthesized
出典と根拠
- ORDレコード
- ord-1d73ca016b714e09b3b2d5513c4ba371
- 出典データセット
- uspto-grants-2013_07
- 特許番号
- US08486940B2
反応ノート
読み込み中…